Organon OGN
NYSE OGN
$13.75 +0.01 (+0.07%)
At close: Aug 21, 2026 · 4:00 PM EDT

Organon (OGN) Gross Margin (2020 - 2026)

Organon (OGN) posted quarterly Gross Margin of 54.36% for Q2 2026, down 47.0% year-over-year from 102.57% in Q2 2025, and up 1.37% on a QoQ basis from 53.63% in Q1 2026.

Organon (OGN) Gross Margin (2020 - 2026) Analysis & Trends

Organon has reported Gross Margin for 7 years, with the latest figure at 54.36% in Q2 2026.

  • Gross Margin for Q2 2026 came in at 54.36%, down 47.0% year-over-year; the trailing twelve-month figure through Jun 2026 was 52.68% (down 358.0% YoY), and the FY2025 annual result was 53.3%, down 472.0% from the prior year.
  • Gross Margin climbed to 54.36% in Q2 2026, from 53.63% in the prior quarter.
  • Over five years, Gross Margin peaked at 64.2% in Q1 2022 and troughed at 49.17% in Q4 2025.
  • A 5-year average of 57.99% and a median of 58.39% in 2024 frame the typical range for Gross Margin.
  • The widest annual swing landed in 2022, when Gross Margin jumped 344 bps; it then plunged 711 bps in 2025.
  • A 5-year view of Gross Margin shows it stood at 60.0% in 2022, then declined by 5 bps to 57.26% in 2023, then retreated by 2 bps to 56.28% in 2024, then retreated by 13 bps to 49.17% in 2025, then rose by 11 bps to 54.36% in 2026.
  • Per Business Quant data, the three most recent Gross Margin figures were 54.36% in Q2 2026, 53.63% in Q1 2026, and 49.17% in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Johnson & Johnson 652.20 Bn 631.44 Bn 17.26 Bn 68.19%
2 AbbVie 469.51 Bn 462.94 Bn 12.70 Bn 74.74%
3 Merck 376.81 Bn 369.67 Bn 12.21 Bn 73.54%
4 Novartis Ag 303.04 Bn 295.35 Bn 11.24 Bn 78.02%
5 Astrazeneca 257.61 Bn 252.71 Bn 12.86 Bn 83.60%
6 Amgen 237.37 Bn 223.38 Bn 7.24 Bn 72.04%
7 Gilead Sciences 181.73 Bn 178.55 Bn 6.22 Bn 79.76%
8 Pfizer 159.66 Bn 147.96 Bn 10.94 Bn 72.78%
9 Gsk 106.24 Bn 102.07 Bn 8.24 Bn 73.05%
10 Organon 3.61 Bn 2.48 Bn 847.00 Mn 54.36%

Historic Data

Download Data
DateValue
Jun 30, 2026 54.36%
Mar 31, 2026 53.63%
Dec 31, 2025 49.17%
Sep 30, 2025 53.50%
Jun 30, 2025 54.83%
Mar 31, 2025 55.58%
Dec 31, 2024 56.28%
Sep 30, 2024 58.34%
Jun 30, 2024 58.43%
Mar 31, 2024 59.00%
Dec 31, 2023 57.26%
Sep 30, 2023 59.71%
Jun 30, 2023 60.20%
Mar 31, 2023 62.29%
Dec 31, 2022 60.00%
Sep 30, 2022 64.15%
Jun 30, 2022 62.90%
Mar 31, 2022 64.20%
Dec 31, 2021 62.63%
Sep 30, 2021 61.94%